Home › Funds › Paradigm Biocapital Advisors LP › KARD

Paradigm Biocapital Advisors LP position in KARD

KARDIGAN INC

Paradigm Biocapital Advisors LP reported holding 900,000 shares of KARD (KARDIGAN INC) in its Q3 2026 13F filing — a position valued at US$13.3M, representing 0.26% of its reported portfolio and ranking #27 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed KARD holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)900.00K sh
Reported value held$13.28M
Portfolio Weight0.26%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's KARD position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in KARD in Q2 2026 at 900,000 shares (US$21.5M). Across 2 filings, Paradigm Biocapital Advisors LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 900,000 shares valued at US$13.3M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 900.00K $21.46M New
Q3 2026 900.00K $13.28M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KARD and 13F data

KARD (KARDIGAN INC) is a company whose sector is not yet classified in our data. 91 other funds we track also report a position in KARD — the largest reported positions include HRTG GPE, LLC (US$249.5M), PERCEPTIVE ADVISORS LLC (US$195.6M), Liberty Mutual Group Asset Management Inc. (US$17.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KARD

All KARD fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held KARD?

Paradigm Biocapital Advisors LP has disclosed KARD holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Paradigm Biocapital Advisors LP's current position in KARD?

As of Q3 2026, Paradigm Biocapital Advisors LP holds 900.00K shares of KARD (KARDIGAN INC), valued at $13.28M, representing 0.26% of its reported portfolio and ranking #27.

Has Paradigm Biocapital Advisors LP been buying or selling KARD?

In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP held unchanged its position in KARD.

Which other funds hold KARD?

Other major institutional holders of KARD include HRTG GPE, LLC, PERCEPTIVE ADVISORS LLC, Liberty Mutual Group Asset Management Inc., among 91 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.